Cargando…

Discovery and Analytical Validation of a Vocal Biomarker to Monitor Anosmia and Ageusia in Patients With COVID-19: Cross-sectional Study

BACKGROUND: The COVID-19 disease has multiple symptoms, with anosmia and ageusia being the most prevalent, varying from 75% to 95% and from 50% to 80% of infected patients, respectively. An automatic assessment tool for these symptoms will help monitor the disease in a fast and noninvasive manner. O...

Descripción completa

Detalles Bibliográficos
Autores principales:	Higa, Eduardo, Elbéji, Abir, Zhang, Lu, Fischer, Aurélie, Aguayo, Gloria A, Nazarov, Petr V, Fagherazzi, Guy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JMIR Publications 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645416/ https://www.ncbi.nlm.nih.gov/pubmed/36265042 http://dx.doi.org/10.2196/35622

Ejemplares similares

Vocal biomarker predicts fatigue in people with COVID-19: results from the prospective Predi-COVID cohort study
por: Elbéji, Abir, et al.
Publicado: (2022)

Recommendations for Successful Implementation of the Use of Vocal Biomarkers for Remote Monitoring of COVID-19 and Long COVID in Clinical Practice and Research
por: Fischer, Aurelie, et al.
Publicado: (2022)

A voice-based biomarker for monitoring symptom resolution in adults with COVID-19: Findings from the prospective Predi-COVID cohort study
por: Fagherazzi, Guy, et al.
Publicado: (2022)

Anosmia and ageusia
por: Tarakji, B., et al.
Publicado: (2020)

Association between use of psychotropic medications prior to SARS-COV-2 infection and trajectories of COVID-19 recovery: Findings from the prospective Predi-COVID cohort study
por: Aguayo, Gloria A., et al.
Publicado: (2023)

The aftermath of COVID-19: between anosmia and ageusia()
por: Medina Gamero, Aldo, et al.
Publicado: (2022)

COVID‐19, anosmia, and ageusia in atopic children
por: Parisi, Giuseppe Fabio, et al.
Publicado: (2022)

Risk Factors Associated With COVID-19 Related Anosmia And Ageusia
por: Sehanobish, Esha, et al.
Publicado: (2021)

Long COVID Symptomatology After 12 Months and Its Impact on Quality of Life According to Initial Coronavirus Disease 2019 Disease Severity
por: Fischer, Aurélie, et al.
Publicado: (2022)

Anosmia and ageusia as presenting complaints of coronavirus disease (COVID-19) infection
por: Mohindra, Ritin, et al.
Publicado: (2020)

Headache associated with COVID-19: Frequency, characteristics and association with anosmia and ageusia
por: Rocha-Filho, Pedro Augusto Sampaio, et al.
Publicado: (2020)

Anosmia and ageusia associated with coronavirus infection (COVID-19) - what is known?
por: Tanasa, Ingrid Andrada, et al.
Publicado: (2020)

Anosmia and Ageusia as the Only Indicators of Coronavirus Disease 2019 (COVID-19)
por: Zhang, Qian, et al.
Publicado: (2020)

Turmeric as a Possible Treatment for COVID-19-Induced Anosmia and Ageusia
por: Chabot, A. Bert, et al.
Publicado: (2021)

Association of COVID19-induced anosmia and ageusia with depression and suicidal ideation
por: Yom-Tov, Elad, et al.
Publicado: (2021)

Sudden anosmia and ageusia in a child: A COVID-19 case report
por: Wang, Ellen, et al.
Publicado: (2021)

Possible Use of Phytochemicals for Recovery from COVID-19-Induced Anosmia and Ageusia
por: Koyama, Sachiko, et al.
Publicado: (2021)

Investigation on the Factors Associated with the Persistence of Anosmia and Ageusia in Saudi COVID-19 Patients
por: Algahtani, Saad N., et al.
Publicado: (2022)

Geographical Variations in Host Predisposition to COVID-19 Related Anosmia, Ageusia, and Neurological Syndromes
por: Kumar, A Aravin, et al.
Publicado: (2021)

Prevalence of Anosmia or Ageusia in Patients With COVID-19 Among United Arab Emirates Population
por: Al-Rawi, Natheer H., et al.
Publicado: (2021)

Viral Shedding and Persistence of Anosmia and Ageusia in an Asymptomatic SARS-CoV-2 Infection
por: Kintrilis, Nikolaos
Publicado: (2023)

Assessment of the Early Detection of Anosmia and Ageusia Symptoms in COVID-19 on Twitter: Retrospective Study
por: Faviez, Carole, et al.
Publicado: (2023)

Prevalence of Anosmia and Ageusia in Patients with COVID-19 at a Primary Health Center, Doha, Qatar
por: Al-Ani, Raid M., et al.
Publicado: (2020)

New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection
por: Patel, A., et al.
Publicado: (2020)

Anosmia and ageusia are emerging as symptoms in patients with COVID-19: What does the current evidence say?
por: Russell, Beth, et al.
Publicado: (2020)

Anosmia and ageusia: a piece of the puzzle in the etiology of COVID-19-related transitory erectile dysfunction
por: Bertolo, R., et al.
Publicado: (2021)

Las secuelas de la COVID-19: entre la anosmia y la ageusia
por: Medina Gamero, Aldo, et al.
Publicado: (2022)

Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study
por: Sampaio Rocha-Filho, Pedro Augusto, et al.
Publicado: (2022)

Case report of familial COVID-19 cluster associated with High prevalence of anosmia, ageusia, and gastrointestinal symptoms
por: Ho, Bethany E., et al.
Publicado: (2020)

Ageusia and anosmia, a common sign of COVID-19? A case series from four countries
por: Vargas-Gandica, Jair, et al.
Publicado: (2020)

452. Familial Cluster of COVID-19 Cases Associated with High Prevalence of Anosmia, Ageusia, and Gastrointestinal Symptoms
por: Ho, Bethany E, et al.
Publicado: (2020)

Testing for anosmia and ageusia in patients presenting to the emergency department with suspected coronavirus disease 2019 in Saudi Arabia
por: Kentab, Osama Y, et al.
Publicado: (2022)

Does serotonin deficiency lead to anosmia, ageusia, dysfunctional chemesthesis and increased severity of illness in COVID-19?
por: Sen, Amarnath
Publicado: (2021)

Anosmia and Ageusia as Predictive Signs of COVID-19 in Healthcare Workers in Italy: A Prospective Case-Control Study
por: La Torre, Giuseppe, et al.
Publicado: (2020)

Prevalence and Recovery from Newly Onset Anosmia and Ageusia in Covid 19 Patients at our Teritary Care Centre
por: Kandakure, Vinod T., et al.
Publicado: (2021)

Age-dependent appearance of SARS-CoV-2 entry sites in mouse chemosensory systems reflects COVID-19 anosmia-ageusia symptoms
por: Brechbühl, Julien, et al.
Publicado: (2021)

Long COVID Classification: Findings from a Clustering Analysis in the Predi-COVID Cohort Study
por: Fischer, Aurélie, et al.
Publicado: (2022)

Anosmia but Not Ageusia as a COVID-19-Related Symptom among Cancer Patients—First Results from the PAPESCO-19 Cohort Study
por: Zhou, Ke, et al.
Publicado: (2021)

Cutaneous manifestations associated with anosmia, ageusia and enteritis in SARS-CoV-2 infection – A possible pattern? Observational study and review of the literature
por: Birlutiu, Victoria, et al.
Publicado: (2021)

Co-Design of a Voice-Based Digital Health Solution to Monitor Persisting Symptoms Related to COVID-19 (UpcomingVoice Study): Protocol for a Mixed Methods Study
por: Fischer, Aurelie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h2d7j7ce98t58dpb0a5vgtmd3g